The choice between an injection and a gel is more than a preference about needles. It can affect training, daily routines, household contact, supplies, and the way a clinician plans follow-up. The exact product matters because medicines using the same route can still have different labels and instructions.
This guide was checked September 22, 2026 using product information, FDA communications, and clinical guidance. It does not recommend a route or provide a dose schedule. Ask a clinician to explain which approved or compounded medicine is being considered and why it fits your diagnosis and circumstances.
KEEP IN MIND
The useful bits.
- Identify the specific product before comparing injection and gel instructions.
- Topical testosterone can transfer to others and needs product-specific precautions.
- Diagnosis, fertility discussion, and ongoing monitoring matter with either route.
Start with the actual medication
Depo-Testosterone is a testosterone cypionate injection labeled for intramuscular administration. AndroGel 1.62% is a specific topical testosterone gel with its own application and transfer precautions. These examples illustrate why the word injection or gel is not enough to identify the medicine or its instructions.
A compounded injection, gel, or cream is not automatically equivalent to a named approved product. Read approved versus compounded testosterone and request the complete prescription. Do not copy a dose, application site, or administration method from another product because both contain testosterone.
Sources: Pfizer: Depo-Testosterone prescribing information · DailyMed: AndroGel 1.62% prescribing information · FDA: understanding the risks of compounded drugs
Injections require a clear administration and supply plan
Ask who administers the proposed injection and what training is provided if home use is part of the clinician’s plan. Clarify supplies, storage, safe disposal, and the process for reporting a problem. Do not assume that every injectable testosterone product is suitable for self-administration or uses the same route.
If you are uncomfortable with handling the prescribed device or cannot follow the instructions confidently, say so before treatment begins. The solution may involve additional training or a different clinical plan. This guide does not teach an injection technique or advise changing the route specified for a prescription.
Topical gel adds household-contact questions
AndroGel 1.62% carries a warning about secondary exposure to testosterone, particularly in children. Its instructions address washing hands, letting the application area dry, covering it, and washing the application area before anticipated skin-to-skin contact. The precise sites and timing requirements belong to the specific product label.
Tell the clinician if you regularly hold grandchildren, provide hands-on care, or share close skin contact with a partner. Ask how the prescribed product fits those routines and what to do after accidental exposure. A gel may avoid needles, but that convenience does not remove the need for careful handling.
Neither route turns aging into a diagnosis
A clinician should first establish why testosterone treatment is being considered. Guidance connects symptoms or signs with consistently low testosterone confirmed through repeat morning fasting testing and evaluation of the cause. Product labeling retains limits around age-related hypogonadism; choosing a route does not resolve an uncertain diagnosis.
If the conversation begins with which product you want before explaining the test results, return to the clinical rationale. Our testing guide after 50 can help. A provider’s list of available medicines is a service description, not proof that any one of them will help a specific reader.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes · Pfizer: Depo-Testosterone prescribing information · DailyMed: AndroGel 1.62% prescribing information
Monitoring remains important with either route
Ask how symptoms, blood pressure, blood counts, adverse effects, and treatment benefit will be reviewed. Testosterone can suppress sperm production, so discuss fertility goals before starting. Relevant prostate, sleep, and cardiovascular history also belongs in the initial assessment, regardless of whether the medicine is injected or applied to skin.
Do not assume that avoiding needles avoids systemic risks, or that an injection works better for everyone. The clinician should explain how the chosen product affects laboratory timing and follow-up. Our monitoring checklist can help you keep those responsibilities visible alongside the product choice.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Compare the whole practical cost
Request a quote that includes the actual medication, supplies or administration, tests, and clinical reviews. If insurance is involved, verify coverage for the specific product rather than assuming payment for one formulation transfers to another. Ask what happens if the initial route proves difficult to use or the clinician recommends a change.
Use the cost planner for confirmed amounts and the provider reviews for published service descriptions. None of those comparisons replaces individualized prescribing. A useful choice is one that can be used correctly, monitored appropriately, and understood clearly in your own setting.
Sources: Pfizer: Depo-Testosterone prescribing information · DailyMed: AndroGel 1.62% prescribing information
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 22, 2026; prices and availability can change.
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.